Guidelines for Pharmacoeconomic Studies
- 1 December 1994
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 6 (6), 493-497
- https://doi.org/10.2165/00019053-199406060-00002
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Issues in the Conduct of Economic Evaluations of Pharmaceutical ProductsPharmacoEconomics, 1994
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994
- Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysisHealth Economics, 1994
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994
- Healthy-years Equivalents versus Quality-adjusted Life YearsMedical Decision Making, 1993
- QALYs, HYEs, and the Loss of InnocenceMedical Decision Making, 1993
- Standardizing Methodologies for Economic Evaluation in Health Care: Practice, Problems, and PotentialInternational Journal of Technology Assessment in Health Care, 1993
- Cost-utility in practice: A policy maker's guide to the state of the artHealth Policy, 1992
- Cost-Effectiveness and Cost-Benefit Analyses in the Medical LiteratureAnnals of Internal Medicine, 1992
- Economic Evaluation of DrugsPharmacoEconomics, 1992